A detailed history of Vestcor Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Vestcor Inc holds 297,465 shares of GILD stock, worth $20.4 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
297,465
Previous 306,309 2.89%
Holding current value
$20.4 Million
Previous $24.8 Million 12.19%
% of portfolio
0.75%
Previous 0.84%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$71.58 - $87.29 $633,053 - $771,992
-8,844 Reduced 2.89%
297,465 $21.8 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $20,808 - $23,597
-284 Reduced 0.09%
306,309 $24.8 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $505,897 - $551,944
6,842 Added 2.28%
306,593 $23 Million
Q2 2023

Aug 15, 2023

SELL
$76.01 - $86.7 $347,213 - $396,045
-4,568 Reduced 1.5%
299,751 $23.1 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $5.67 Million - $6.47 Million
73,405 Added 31.79%
304,319 $25.2 Million
Q4 2022

Feb 15, 2023

BUY
$62.32 - $89.47 $388,876 - $558,292
6,240 Added 2.78%
230,914 $19.8 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $129,023 - $147,377
2,167 Added 0.97%
224,674 $13.9 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $298,181 - $335,841
5,166 Added 2.38%
222,507 $13.8 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $75,527 - $94,644
-1,304 Reduced 0.6%
217,341 $12.9 Million
Q4 2021

Feb 15, 2022

SELL
$64.88 - $73.64 $710,760 - $806,726
-10,955 Reduced 4.77%
218,645 $15.9 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $453,455 - $489,227
-6,699 Reduced 2.83%
229,600 $16 Million
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $313,224 - $342,242
-4,935 Reduced 2.05%
236,299 $16.3 Million
Q1 2021

May 17, 2021

BUY
$60.0 - $68.46 $1.54 Million - $1.76 Million
25,701 Added 11.92%
241,234 $15.6 Million
Q4 2020

Feb 16, 2021

BUY
$56.65 - $64.55 $1.19 Million - $1.36 Million
21,085 Added 10.84%
215,533 $12.6 Million
Q3 2020

Nov 16, 2020

SELL
$62.1 - $78.08 $48,065 - $60,433
-774 Reduced 0.4%
194,448 $12.3 Million
Q2 2020

Aug 14, 2020

BUY
$72.34 - $84.0 $12.2 Million - $14.1 Million
168,134 Added 620.7%
195,222 $15 Million
Q1 2020

May 13, 2020

BUY
$62.63 - $80.22 $322,544 - $413,133
5,150 Added 23.48%
27,088 $2.03 Million
Q4 2019

Feb 12, 2020

BUY
$61.62 - $67.78 $1.35 Million - $1.49 Million
21,938 New
21,938 $1.43 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $86B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Vestcor Inc Portfolio

Follow Vestcor Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.